Roundtable: Diagnostics Licensing Terms

Conveners: HIV Policy Lab
Role: Supported convening, organised research assistants acting as rapporteurs and brought together the meeting report
Date: 19 November 2021
Location: Virtual

The goal of the Roundtable was to generate recommendations for licensing terms for diagnostics. We hope the record of these discussions and the recommendations that resulted will help guide the work and strategy of various actors, including the Medicines Patent Pool (MPP) to support diagnostics access (including beyond COVID-19) through sharing of technical know-how and pooling of intellectual property.

Roundtable on Diagnostics Licensing Terms — Meeting Report Meeting report (PDF)

Roundtable participants included representatives from PATH, the Medicines Patent Pool, Northeastern, Partners in Diagnostics, ICGEB, Mologic, FIND, Penn Medicine, UNDP, the Open Society Foundation, Yale, CHAI, Gombe, DNDi, SUN Zimbabwe, WHO, UNITAID, Cambridge, LSHTM and KEI.